Pegasus Pharmaceuticals Inc. And HeartView To Market Its HeartVue 6S Screening Device In Europe

PALM BEACH GARDENS, FL -- (MARKET WIRE) -- October 30, 2006 -- Pegasus/HeartView, LLC (PINKSHEETS: PGUZ) today announced that they are anticipating an EU CE Mark approval during November 2006 for their advanced screening technology, the HeartVue 6S System.

Back to news